Capstone Triton Financial Group’s GSK GSK Stock Holding History

Capstone Triton Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$237K	Sell	6,996 -785	-10%	-$28.3K	0.15%	98
2024 Q3	$318K	Sell	7,781 -669	-8%	-$27.4K	0.2%	87
2024 Q2	$325K	Sell	8,450 -1,409	-14%	-$59.3K	0.23%	83
2024 Q1	$423K	Buy	9,859 +414	+4%	+$17.1K	0.3%	78
2023 Q4	$350K	Sell	9,445 -1,600	-14%	-$57.4K	0.26%	83
2023 Q3	$400K	Hold	11,045	–	–	0.29%	72
2023 Q2	$394K	Hold	11,045	–	–	0.27%	74
2023 Q1	$393K	Sell	11,045 -514	-4%	-$18K	0.3%	74
2022 Q4	$406K	Sell	11,559 -3,519	-23%	-$117K	0.33%	74
2022 Q3	$444K	Buy	+15,078	New	+$571K	0.38%	70
2022 Q2	–	Sell	-23,902	Closed	-$1.36M	–	102
2022 Q1	$1.36M	Buy	23,902 +176	+0.7%	+$9.56K	0.95%	34
2021 Q4	$1.31M	Sell	23,726 -76	-0.3%	-$3.95K	2.64%	2
2021 Q3	$1.18M	Sell	23,802 -1,272	-5%	-$63.9K	0.71%	35
2021 Q2	$1.25M	Sell	25,074 -2,318	-8%	-$111K	0.77%	41
2021 Q1	$1.22M	Sell	27,392 -3,658	-12%	-$166K	0.81%	38
2020 Q4	$1.43M	Buy	+31,050	New	+$1.43M	0.87%	33

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capstone Triton Financial Group's GSK Position: Q4 2024 in Review

Capstone Triton Financial Group reduced its GSK (GSK) stake by 10% in Q4 2024, selling an estimated $28.3K and leaving 6,996 shares worth $237K. The position accounts for 0.15% of the portfolio, ranked #98.

Capstone Triton Financial Group first reported a position in GSK in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.43M in Q4 2020. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Capstone Triton Financial Group held 6,996 shares of GSK worth $237K as of Q4 2024.
Capstone Triton Financial Group sold 785 GSK shares in Q4 2024, an estimated $28.3K.
GSK made up 0.15% of Capstone Triton Financial Group's portfolio in Q4 2024, its #98 holding.
Capstone Triton Financial Group first reported a position in GSK in Q4 2020 and has held it in 16 quarters since.
Capstone Triton Financial Group's GSK position peaked at $1.43M in Q4 2020.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Capstone Triton Financial Group's 13F filing for Q4 2024, filed 10 Mar 2025.